{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:24:18Z","timestamp":1772724258922,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The case study discusses a complex scenario involving the use of amoxicillin in a critically ill patient undergoing intermittent renal replacement therapy.<\/jats:p>\n            <jats:p>Severe infections are complicated by septic shock and organ failure, requiring urgent and effective antibiotic treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The patient's comorbidities, including obesity and acute kidney injury, required careful consideration of the amoxicillin dosing strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Therapeutic drug monitoring is critical for dose adjustment during treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This case highlights the importance of a collaborative approach between clinicians and therapeutic drug monitoring consultants to optimize antibiotic therapy for critically ill patients with renal impairment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001242","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:12:35Z","timestamp":1719857555000},"page":"559-562","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Personalized Amoxicillin Therapy in a Critically Ill Patient Undergoing Renal Replacement Therapy: A Grand Round"],"prefix":"10.1097","volume":"46","author":[{"given":"Philippine","family":"Garrigue","sequence":"first","affiliation":[{"name":"Pharmacie \u00e0 usage int\u00e9rieur, CHU de Saint Etienne, Saint Etienne, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Reber","sequence":"additional","affiliation":[{"name":"M\u00e9decine Intensive R\u00e9animation G, CHU de Saint-Etienne, Saint Etienne, France; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Perinel-Ragey","sequence":"additional","affiliation":[{"name":"M\u00e9decine Intensive R\u00e9animation G, CHU de Saint-Etienne, Saint Etienne, France; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-7301","authenticated-orcid":false,"given":"Manon","family":"Launay","sequence":"additional","affiliation":[{"name":"M\u00e9decine Intensive R\u00e9animation G, CHU de Saint-Etienne, Saint Etienne, France; and"},{"name":"Centre R\u00e9gional de Pharmacovigilance, CHU Nord de St Etienne, Saint Etienne, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1111\/bcp.14739","article-title":"Pharmacokinetics of amoxicillin in obese and nonobese subjects","volume":"87","author":"Soares","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1093\/jac\/dkaa368","article-title":"Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav","volume":"75","author":"Mellon","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00134-003-2059-6","article-title":"Dosing of medications in morbidly obese patients in the intensive care unit setting","volume":"30","author":"Erstad","year":"2004","journal-title":"Intensive Care Med"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"dlac080","DOI":"10.1093\/jacamr\/dlac080","article-title":"Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study","volume":"4","author":"Hughes","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmi.2020.11.032","article-title":"Does dose reduction of renally cleared antibiotics in patients with impaired renal function lead to adequate drug exposure? A systematic review","volume":"27","author":"de Vroom","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.xphs.2017.04.068","article-title":"Biowaiver monograph for immediate-release solid oral dosage forms: amoxicillin trihydrate","volume":"106","author":"Thambavita","year":"2017","journal-title":"J Pharm Sci"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13613-015-0093-5","article-title":"Renal replacement therapy in adult and pediatric intensive care: recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD)","volume":"5","author":"Vinsonneau","year":"2015","journal-title":"Ann Intensive Care"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"005833-19","DOI":"10.1128\/AAC.00583-19","article-title":"A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy","volume":"63","author":"Pistolesi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d'Anesth\u00e9sie et R\u00e9animation-SFAR)","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/antibiotics12040680","article-title":"Amoxicillin-induced neurotoxicity: contribution of a healthcare data warehouse to the determination of a toxic concentration threshold","volume":"12","author":"Lalanne","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/ndt\/gfab074","article-title":"Amoxicillin crystalluria is associated with acute kidney injury in patients treated for acute infective endocarditis","volume":"36","author":"Jamme","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ndt\/gfr389","article-title":"Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis","volume":"27","author":"Walther","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12882-019-1272-7","article-title":"Urea reduction ratio may be a simpler approach for measurement of adequacy of intermittent hemodialysis in acute kidney injury","volume":"20","author":"Liang","year":"2019","journal-title":"BMC Nephrol"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/jac\/dkad002","article-title":"Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis","volume":"78","author":"Solli","year":"2023","journal-title":"J Antimicrob Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:09:39Z","timestamp":1748970579000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001242","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"2024-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}